Player Avatar SophicF00L (< 20) Submitted: 11/8/2012 3:38:34 PM : Outperform Start Price: $14.46 MAKO.DL Score: +82.85

The number of robotic arms sold increased this quarter (15 sold 3Q 2012) and it's just beginning to get traction in the medical community. Once these 'razors' are sold, the 'blades' will follow and I like the prospects, especially with the new hip application on top of the knee application. I have this in my portfolio and I am continuing to buy at these levels ($14 - $16 range). There is the possibility of the use of the robotic arm to be expanded to include shoulders, though there is nothing definite about that other than rumors. Still, I like the long term growth possibilities with this company and I'm backing it as part of my aggressive section of my portfolio.

Featured Broker Partners